The compound has never received market authorization in Canada or anywhere else, and Metabolic Pharmaceuticals terminated clinical development in 2007 after the Phase IIb obesity trial failed
Recognizing the Signs of Thrombocytopenia The symptoms of thrombocytopenia can vary based on how severe it is
Primary research applications include Alzheimer's disease, vascular dementia, age-related cognitive decline, and neurological recovery after brain injury
Testing may include ACTH and cortisol, thyroid hormones, FSH, LH, testosterone or estradiol, prolactin, DHEA-S, pregnenolone, growth hormone and IGF-1
The experiments were assessed by observers blinded as to the treatment